genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Topics
Genome Editing
Page 2
Genome Editing
Artificial Intelligence
Bioprocessing
Cancer
Coronavirus
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Genome Editing
Successful Step Made toward Synthetic Genomes
Genome Editing
Oxford BioMedica to Obtain $250K to Support Gene Therapy for Stargardt Disease
Genome Editing
IDT Purchases VH Bio’s Oligo Segment
Genome Editing
Scientists Create Targeted Knockout Rats Using Sangamo’s Zinc Finger Nuclease Technology
Genome Editing
DNA2.0 Reveals Intricacies Involved in Optimized Gene Design
Genome Editing
OriGene Picks Up Gene-Synthesis Firm Blue Heron Biotechnology
Genome Editing
Monash University Collaborates with Cryo-Cell to Investigate Menstrual Stem Cell Therapy...
Genome Editing
Lonza Acquires Vivante to Expand into Viral-Based GMP Manufacturing
Genome Editing
Progenika Gets CE Mark for LPL Gene Chip for Use with...
Genome Editing
Novartis Teams with Synthetic Genomics Vaccines to Develop Flu Seed Virus...
Genome Editing
Phase I Gene Therapy Study Reveals Unexpected Dystrophin Immunity in DMD...
Genome Editing
Diamyd Separates Pain and Diabetes Divisions to Boost Gene Therapies for...
Genome Editing
Jackson Laboratory to Distribute Sigma Life Sciences’ Transgenic Mice
Genome Editing
Tate & Lyle to Manufacture Farnesene for Amyris
Genome Editing
Ceregene Pockets $11.5M to Support Mid-Stage Parkinson Disease Trial
1
2
3
...
186
Page 2 of 186
Scroll Up
Scroll Up
![Company’s expertise will bolster Origene’s gene-based services. [© Gernot Krautberger - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug13_2010_2716446_FemSciCutsDNAScissors_OrigeneMAblueHeron1931222811-324x160.jpg "OriGene Picks Up Gene-Synthesis Firm Blue Heron Biotechnology")
![New product joins CE-marked chips for blood-donor compatibility and familial hypercholesterolemia. [© krishnacreations - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Sept27_2010_18919434_DigestiveSystem_EUapprovesProgenikaLPLDTest4747505814-324x160.jpg "Progenika Gets CE Mark for LPL Gene Chip for Use with AMT’s Gene Therapy")
![Company was established by Synthetic Genomics and J. Craig Venter Institute to develop synthetic vaccines.[ktsdesign-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesOct2010May21_2010_3986080_PurpleBlueDNAStripes_JCVenterSyntheticBio1533713141-324x160.jpg "Novartis Teams with Synthetic Genomics Vaccines to Develop Flu Seed Virus Banks")
![Small amounts of naturally produced protein from self-correcting genes likely prime patients’ immune systems.[© Studio Pookini - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesOct2010Oct7_2010_7388606_BoyinWheelchair_DMDgeneTherapyImmunityDystrophin1322645210-324x160.jpg "Phase I Gene Therapy Study Reveals Unexpected Dystrophin Immunity in DMD Patients")
